Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0767-5
- By:
- Publication type:
- Article
Works matching IS 15233790 AND DT 2019 AND VI 21 AND IP 2
Results: 9
1
2
Novel Approaches for Treating Pain in Children.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0766-6
- By:
- Publication type:
- Article
3
Communicating with Adolescents and Young Adults about Cancer-Associated Weight Loss.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0765-7
- By:
- Publication type:
- Article
4
New Treatment Options for Acute Myeloid Leukemia in 2019.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0764-8
- By:
- Publication type:
- Article
5
Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0763-9
- By:
- Publication type:
- Article
6
BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0762-x
- By:
- Publication type:
- Article
7
TRK Inhibitors: Clinical Development of Larotrectinib.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0761-y
- By:
- Publication type:
- Article
8
Pegylated Interleukin-10: Clinical Development of an Immunoregulatory Cytokine for Use in Cancer Therapeutics.
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0760-z
- By:
- Publication type:
- Article
9
Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
- Published in:
- Current Oncology Reports, 2019, v. 21, n. 2, p. 1, doi. 10.1007/s11912-019-0759-5
- By:
- Publication type:
- Article